Candriam Equities L Biotech.I GBP Acc/ LU1269737059 /
| NAV02/05/2024 | Chg.+107.8699 | Type de rendement | Focus sur l'investissement | Société de fonds |
|---|---|---|---|---|
| 3,369.9399GBP | +3.31% | reinvestment | Equity Worldwide | Candriam ▶ |
Performance mensuelle
| janv. | févr. | mars | avr. | mai | juin | juil. | août | sept. | oct. | nov. | déc. | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016 | - | - | - | 1.64 | 6.04 | -0.12 | 13.33 | -1.09 | 4.68 | -6.72 | 6.19 | -1.75 | - |
| 2017 | 3.79 | 8.04 | -0.55 | -2.13 | -2.82 | 8.54 | 1.05 | 8.83 | -3.11 | -5.36 | -1.59 | 1.59 | +16.06% |
| 2018 | 1.61 | -1.63 | -3.64 | -1.30 | 8.37 | 1.78 | 5.19 | 5.17 | -2.34 | -12.18 | 4.36 | -8.08 | -4.56% |
| 2019 | 9.61 | 2.35 | 1.48 | -4.90 | -1.46 | 8.35 | 1.42 | -1.75 | -5.56 | 5.58 | 11.94 | 0.07 | +28.66% |
| 2020 | -4.76 | 2.04 | -2.16 | 10.91 | 11.53 | 1.46 | -8.51 | -1.07 | 4.34 | -2.82 | 6.39 | 0.66 | +17.29% |
| 2021 | 1.42 | -4.25 | -2.92 | 2.44 | -4.49 | 9.25 | -2.01 | 5.05 | -2.18 | -1.72 | -0.76 | -0.59 | -1.63% |
| 2022 | -9.93 | -1.98 | 7.73 | -3.11 | -3.70 | 6.91 | 4.41 | 5.70 | 2.20 | 3.71 | 2.65 | -3.74 | +9.66% |
| 2023 | 0.63 | -4.09 | -1.65 | 0.61 | 0.20 | -1.29 | -1.32 | 1.37 | -0.65 | -5.57 | 1.60 | 12.72 | +1.50% |
| 2024 | 1.44 | 2.04 | 0.19 | -5.29 | 3.31 | - | - | - | - | - | - | - | - |
Valeurs calculées
| CAD | 6 Mois | 1 An | 3 Ans | 5 Ans | |
|---|---|---|---|---|---|
| Volatilité | 17.51% | 18.52% | 16.58% | 20.81% | 23.53% |
| Ratio de Sharpe | 0.04 | 1.39 | 0.20 | 0.06 | 0.23 |
| Le meilleur mois | +12.72% | +12.72% | +12.72% | +12.72% | +12.72% |
| Le plus défavorable mois | -5.29% | -5.29% | -5.57% | -9.93% | -9.93% |
| Perte maximale | -9.21% | -9.21% | -11.90% | -21.19% | -23.19% |
| Surperformance | -3.11% | - | -0.37% | - | - |
Toutes les cotations dans GBP
Tranches
| Nom | Type de rendement | Prix de rachat | 1 An | 3 Ans | |
|---|---|---|---|---|---|
| Candriam Equities L Biotechnolog... | reinvestment | 2,005.2800 | +7.40% | +5.34% | |
| Candriam Equities L Biotech.C EU... | reinvestment | 217.3000 | +9.72% | - | |
| Candriam Equities L Biotech.I-H ... | reinvestment | 2,010.0900 | +5.01% | -2.02% | |
| Candriam Equities L Biotech.I EU... | reinvestment | 2,188.1899 | +10.22% | +18.62% | |
| Candriam Equities L Biotech.I GB... | reinvestment | 3,369.9399 | +7.08% | +15.89% | |
| Candriam Equities L Biotech.R GB... | reinvestment | 353.9900 | +7.59% | +19.68% | |
| Candriam Equities L Biotech.R EU... | reinvestment | 320.4600 | +10.74% | +21.20% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 196.3100 | +3.02% | -3.36% | |
| Candriam Equities L Biotech.V2 U... | reinvestment | 1,795.9900 | +8.08% | +8.09% | |
| Candriam Equities L Biotech.N-H ... | reinvestment | 145.7800 | - | - | |
| Candriam Equities L Biotech.N US... | reinvestment | 584.4100 | +6.48% | +3.36% | |
| Candriam Equities L Biotech.I US... | reinvestment | 5,486.2402 | +7.27% | +4.95% | |
| Candriam Equities L Biotech.C-H ... | reinvestment | 192.5500 | +4.61% | -2.32% | |
| Candriam Equities L Biotech.R-H ... | reinvestment | 200.6900 | +5.50% | +0.08% | |
| Candriam Equities L Biotech.R US... | reinvestment | 260.3500 | +7.81% | +7.28% | |
| Candriam Equities L Biotechnolo... | reinvestment | 820.1800 | +6.87% | +4.67% | |
| Candriam Equities L Biotechnolog... | paying dividend | 749.0700 | +6.83% | +4.57% |
Performance
| CAD | +1.47% | ||
|---|---|---|---|
| 6 Mois | +13.74% | ||
| 1 An | +7.08% | ||
| 3 Ans | +15.89% | ||
| 5 Ans | +55.52% | ||
| Depuis le début | +124.66% | ||
| Année | |||
| 2023 | +1.50% | ||
| 2022 | +9.66% | ||
| 2021 | -1.63% | ||
| 2020 | +17.29% | ||
| 2019 | +28.66% | ||
| 2018 | -4.56% | ||
| 2017 | +16.06% | ||
